CORRESP Filing
BridgeBio Oncology Therapeutics, Inc.
Date: July 9, 2025 · CIK: 0001869105 · Accession: 0001213900-25-062226
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-288222
Letter
Re: Acceleration Request for Helix Acquisition Corp. II and TheRas, Inc.
Helix Acquisition Corp. II 200 Clarendon Street, 52 nd Floor Boston, MA 02116 TheRas, Inc. 256 E. Grand Avenue, Suite 104 South San Francisco, CA 94080
July 9, 2025
VIA EDGAR
United States Securities and Exchange Commission Division of Corporation Finance Office of Life Sciences
100 F Street NE Washington, D.C. 20549
Registration Statement on Form S-4
File No. 333-288222
Requested Date: July 10, 2025
Requested Time: 4:15 p.m. Eastern Time
Ladies and Gentlemen:
Pursuant to Rule 461 under the Securities Act of 1933, as amended, Helix Acquisition Corp. II and TheRas, Inc. together hereby request that the effective date of the above-captioned Registration Statement on Form S-4, as amended (the "Registration Statement"), be accelerated to, and that the Registration Statement be declared effective at 4:15 p.m., Eastern Time, on July 10, 2025, or as soon as practicable thereafter.
Please contact Joel Rubinstein (email: joel.rubinstein@whitecase.com or telephone: (212) 819-7642) of White & Case LLP or Maggie L. Wong (email: mwong@goodwinlaw.com or telephone: (415) 733-6071) of Goodwin Procter LLP with any questions and please notify one or more of them when this request for acceleration has been granted.
Very truly yours,
TheRas, Inc.
Show Raw Text
CORRESP 1 filename1.htm Helix Acquisition Corp. II 200 Clarendon Street, 52 nd Floor Boston, MA 02116 TheRas, Inc. 256 E. Grand Avenue, Suite 104 South San Francisco, CA 94080 July 9, 2025 VIA EDGAR United States Securities and Exchange Commission Division of Corporation Finance Office of Life Sciences 100 F Street NE Washington, D.C. 20549 Re: Acceleration Request for Helix Acquisition Corp. II and TheRas, Inc. Registration Statement on Form S-4 File No. 333-288222 Requested Date: July 10, 2025 Requested Time: 4:15 p.m. Eastern Time Ladies and Gentlemen: Pursuant to Rule 461 under the Securities Act of 1933, as amended, Helix Acquisition Corp. II and TheRas, Inc. together hereby request that the effective date of the above-captioned Registration Statement on Form S-4, as amended (the "Registration Statement"), be accelerated to, and that the Registration Statement be declared effective at 4:15 p.m., Eastern Time, on July 10, 2025, or as soon as practicable thereafter. Please contact Joel Rubinstein (email: joel.rubinstein@whitecase.com or telephone: (212) 819-7642) of White & Case LLP or Maggie L. Wong (email: mwong@goodwinlaw.com or telephone: (415) 733-6071) of Goodwin Procter LLP with any questions and please notify one or more of them when this request for acceleration has been granted. Very truly yours, TheRas, Inc. Helix Acquisition Corp. II By: /s/ Eli Wallace By: /s/ Bihua Chen Name: Eli Wallace Name: Bihua Chen Title: Chief Executive Officer Title: Chief Executive Officer cc: Joel Rubinstein, White & Case LLP Maggie L. Wong., Goodwin Procter LLP